250 related articles for article (PubMed ID: 16979621)
21. New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists.
Smith PW; Cooper AW; Bell R; Beresford IJ; Gore PM; McElroy AB; Pritchard JM; Saez V; Taylor NR; Sheldrick RL
J Med Chem; 1995 Sep; 38(19):3772-9. PubMed ID: 7562907
[TBL] [Abstract][Full Text] [Related]
22. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
[TBL] [Abstract][Full Text] [Related]
24. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
25. Different mechanism of tachykinin NK2 receptor blockade by SR 48968 and MEN 10,627 in the guinea-pig isolated gallbladder and colon.
Patacchini R; De Giorgio R; Giachetti A; Maggi CA
Eur J Pharmacol; 1994 Dec; 271(1):111-9. PubMed ID: 7698194
[TBL] [Abstract][Full Text] [Related]
26. In vivo effects of neurokinin B on rat urinary bladder motility: involvement of tachykinin NK1 and NK2 receptors.
Lecci A; Giuliani S; Meini S; Maggi CA
Neuropeptides; 1994 Jul; 27(1):53-62. PubMed ID: 7969819
[TBL] [Abstract][Full Text] [Related]
27. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the presence of a septide-sensitive tachykinin receptor in the circular muscle of the guinea-pig ileum.
Maggi CA; Patacchini R; Meini S; Giuliani S
Eur J Pharmacol; 1993 Apr; 235(2-3):309-11. PubMed ID: 7685292
[TBL] [Abstract][Full Text] [Related]
30. Tachykinin NK1 and NK2 receptors mediate the non-cholinergic bronchospastic response to capsaicin and vagal stimulation in guinea-pigs.
Boni P; Ballati L; Evangelista S
J Auton Pharmacol; 1995 Feb; 15(1):49-54. PubMed ID: 7538136
[TBL] [Abstract][Full Text] [Related]
31. Substance P-induced contractions of the guinea-pig proximal colon through stimulation of post-junctional tachykinin NK1 receptors.
Briejer MR; Akkermans LM; Meulemans AL; Lefebvre RA; Schuurkes JA
Eur J Pharmacol; 1993 Nov; 250(1):181-3. PubMed ID: 7509752
[TBL] [Abstract][Full Text] [Related]
32. The rabbit iris sphincter contains NK1 and NK3 but not NK2 receptors: a study with selective agonists and antagonists.
Wang ZY; Håkanson R
Regul Pept; 1993 Apr; 44(3):269-75. PubMed ID: 7683436
[TBL] [Abstract][Full Text] [Related]
33. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
[TBL] [Abstract][Full Text] [Related]
34. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.
Giuliani S; Barbanti G; Turini D; Quartara L; Rovero P; Giachetti A; Maggi CA
Eur J Pharmacol; 1991 Oct; 203(3):365-70. PubMed ID: 1723045
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
[TBL] [Abstract][Full Text] [Related]
36. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
37. GR 73,632 and [Glu(OBzl)11]substance P are selective agonists for the septide-sensitive tachykinin NK1 receptor in the rat urinary bladder.
Meini S; Patacchini R; Lecci A; Poulos C; Rovero P; Maggi CA
Neuropeptides; 1995 Feb; 28(2):99-106. PubMed ID: 7538205
[TBL] [Abstract][Full Text] [Related]
38. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
[TBL] [Abstract][Full Text] [Related]
39. Specialization of tachykinin NK1 and NK2 receptors in producing fast and slow atropine-resistant neurotransmission to the circular muscle of the guinea-pig colon.
Maggi CA; Zagorodnyuk V; Giuliani S
Neuroscience; 1994 Dec; 63(4):1137-52. PubMed ID: 7535393
[TBL] [Abstract][Full Text] [Related]
40. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
Lecci A; Giuliani S; Patacchini R; Maggi CA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1327-32. PubMed ID: 8383746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
